Metal nanoparticles as a potential technique for the diagnosis and treatment of gastrointestinal cancer: a comprehensive review

• Published in: Cancer cell international Vol. 23; no. 1; pp. 1 - 280
• Main Authors: Roshani, Mohammad, Rezaian-Isfahni, Arya, Lotfalizadeh, Mohammad Hassan, Khassafi, Negar, Abadi, Mohammad Hassan Jafari Najaf, Nejati, Majid
• Format: Journal Article
• Language: English
• Published: London BioMed Central 19.11.2023; BMC
• Subjects: Ablation; Antigen (tumor-associated); Antimicrobial agents; Cancer therapies; Chemical elements; Chemotherapy; Colon; Cytotoxicity; Diagnosis; DNA methylation; Drug delivery; Esophagus; Gastrointestinal cancer; Gastrointestinal cancers; Gold; Lifestyles; Localization; Medical diagnosis; Metal nanoparticles; Metals; MicroRNAs; Mortality; Nanoparticles; Oxidation; Radiation therapy; Silver; Solubility; Therapy; Toxicity; Tumor cells; Tumors; Zinc
• ISSN: 1475-2867; 1475-2867
• DOI: 10.1186/s12935-023-03115-1

Gastrointestinal (GI) cancer is a major health problem worldwide, and current diagnostic and therapeutic approaches are often inadequate. Various metallic nanoparticles (MNPs) have been widely studied for several biomedical applications, including cancer. They may potentially overcome the challenges associated with conventional chemotherapy and significantly impact the overall survival of GI cancer patients. Functionalized MNPs with targeted ligands provide more efficient localization of tumor energy deposition, better solubility and stability, and specific targeting properties. In addition to enhanced therapeutic efficacy, MNPs are also a diagnostic tool for molecular imaging of malignant lesions, enabling non-invasive imaging or detection of tumor-specific or tumor-associated antigens. MNP-based therapeutic systems enable simultaneous stability and solubility of encapsulated drugs and regulate the delivery of therapeutic agents directly to tumor cells, which improves therapeutic efficacy and minimizes drug toxicity and leakage into normal cells. However, metal nanoparticles have been shown to have a cytotoxic effect on cells in vitro. This can be a concern when using metal nanoparticles for cancer treatment, as they may also kill healthy cells in addition to cancer cells. In this review, we provide an overview of the current state of the field, including preparation methods of MNPs, clinical applications, and advances in their use in targeted GI cancer therapy, as well as the advantages and limitations of using metal nanoparticles for the diagnosis and treatment of gastrointestinal cancer such as potential toxicity. We also discuss potential future directions and areas for further research, including the development of novel MNP-based approaches and the optimization of existing approaches.